--- title: "U.S. stock market midday update: Picard Medical up 16.55% with no major positive news, capital movement causes fluctuations" type: "News" locale: "en" url: "https://longbridge.com/en/news/297811461.md" description: "Picard Medical rose 16.55%; Medtronic rose 2.00%, with a transaction volume of USD 367 million; Abbott rose 2.76%, with a transaction volume of USD 345 million; Boston Scientific rose 2.82%, with a transaction volume of USD 319 million; Intuitive Surgical rose 2.42%, with a market capitalization of USD 133.6 billion" datetime: "2026-09-02T16:24:07.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/297811461.md) - [en](https://longbridge.com/en/news/297811461.md) - [zh-HK](https://longbridge.com/zh-HK/news/297811461.md) generator: "portal-rs" --- # U.S. stock market midday update: Picard Medical up 16.55% with no major positive news, capital movement causes fluctuations **U.S. Stock Market Midday Update** Picard Medical rose 16.55%. There has been no significant news recently; trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no\_news **Top Stocks by Industry Trading Volume** Medtronic rose 2.00%. Based on recent key news: 1. On September 1, Medtronic reached a strategic partnership with Cornerstone Robotics, investing $700 million and gaining distribution rights outside the U.S. This move expands Medtronic's influence in the robotic-assisted surgery field, driving the stock price up. 2. On September 2, Medtronic announced its quarterly earnings report, with revenue increasing by 13.7% year-over-year, exceeding market expectations. Strong performance boosted investor confidence, leading to a rise in stock price. 3. On September 3, analysts raised Medtronic's target price to $104, reflecting market optimism about its future growth, further supporting the stock price increase. The medical technology industry is performing strongly, with significant capital inflows. Abbott rose 2.76%. Based on recent key news: 1. On August 31, Abbott announced it would begin selling a new Similac infant formula, the first sterile liquid formula in the U.S. to use whole milk. This news drove the stock price up. 2. On August 31, Abbott stated that each batch of products would be produced at its manufacturing facilities in the U.S. This move enhanced market confidence in its production capabilities, further driving the stock price up. 3. On September 2, Abbott's Libre Duo became the first 2-in-1 continuous glucose monitoring device authorized by the FDA. The launch of this innovative product raised market expectations for Abbott's future growth, resulting in a stock price increase. The medical industry has performed strongly recently, with innovative products driving stock price up. Boston Scientific rose 2.82%. Based on recent news: 1. On August 26, Boston Scientific experienced a cybersecurity incident that disrupted global operations, including some information systems used for processing and shipping customer orders. The company detected the incident on August 25 and initiated an incident response program, collaborating with third-party cybersecurity experts to investigate and contain the threat. 2. On August 31, Boston Scientific entered into a distribution agreement with Cerenovus, covering global market distribution for multiple products. This agreement helps expand Boston Scientific's market coverage and enhance company performance. 3. On September 2, analyst ratings indicated that Boston Scientific is currently rated as "Moderate Buy," but top analysts believe there are five stocks that are more worthy of purchase, which may have affected some investors' confidence. The medical device industry has performed strongly recently, with increased cybersecurity risks. **Top Stocks by Industry Market Capitalization** Intuitive Surgical rose 2.42%. Based on recent key news: 1. On September 2, Intuitive Surgical installed 468 da Vinci systems in the most recent quarter, an increase from 395 units in the same period last year. This brings the company's installation base to 11,710 units as of June 30, a year-on-year increase of 12%. The continued investment by hospitals in robotic systems indicates an optimistic outlook for future demand, which is beneficial for Intuitive Surgical's future growth. Source: Zhitong Finance 2. On August 31, in the international market, there has been rapid progress in the field of gastrointestinal endoscopic surgical robots, with EndoQuest's gastrointestinal intraluminal surgical robot completing key trials, marking a significant step towards commercialization. Intuitive Surgical's entry into this field is seen as an important force in market expansion. Source: Wall Street Insight 3. On September 1, Intuitive Surgical made significant progress in its expansion in the healthcare sector, recently signing a seven-figure deal with a major national health system, fully supported by its OASYS platform. This indicates that the company's influence in this field is increasing. Source: Jinshi Data Medical Robotics Market Competition Intensifies, Growth Potential High ### Related Stocks - [PMI.US](https://longbridge.com/en/quote/PMI.US.md) - [MDT.US](https://longbridge.com/en/quote/MDT.US.md) - [ABT.US](https://longbridge.com/en/quote/ABT.US.md) - [BSX.US](https://longbridge.com/en/quote/BSX.US.md) - [ISRG.US](https://longbridge.com/en/quote/ISRG.US.md) ## Related News & Research - [ENvue Medical announces 1-for-12 reverse stock split](https://longbridge.com/en/news/297559591.md) - [Why the jobs report will actually be good for bonds](https://longbridge.com/en/news/298066649.md) - [Forget High-Yield Traps: Coca-Cola Is the Best Dividend Stock](https://longbridge.com/en/news/298107881.md) - [Cincinnati Financial (CINF) Dropped, So What Is Behind The Latest Attention?](https://longbridge.com/en/news/298111175.md) - [Half of Americans are economically insecure. What are we going to do about it?](https://longbridge.com/en/news/298046649.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**